Literature DB >> 3047419

Evaluation of coagulation factor abnormalities in long-acting anticoagulant overdose.

R S Hoffman1, M J Smilkstein, L R Goldfrank.   

Abstract

Newer Rodenticides of the long-acting anticoagulant or "superwarfarin" class are gaining popularity. Since few cases of severe, prolonged anticoagulation after ingestion have been reported, the course of toxicity is not precisely understood. In this case of an intentional ingestion of brodifacoum, a longitudinal analysis of specific coagulation factor derangements was carried out in an attempt to guide a future treatment strategy for this type of toxicity. Results of this analysis demonstrated a profound decrease in levels of factors II, VII, IX, and X, lasting at least 43 days post ingestion. Treatment with subcutaneous vitamin K1 in doses up to 100 milligrams per day was without complication and was effective in reversing the coagulopathy produced by brodifacoum.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3047419     DOI: 10.3109/15563658809000350

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  3 in total

Review 1.  A case of bromadiolone (superwarfarin) ingestion.

Authors:  E Y Chow; L P Haley; L M Vickars; M J Murphy
Journal:  CMAJ       Date:  1992-07-01       Impact factor: 8.262

Review 2.  Superwarfarin (Long-Acting Anticoagulant Rodenticides) Poisoning: from Pathophysiology to Laboratory-Guided Clinical Management.

Authors:  Yeow-Kuan Chong; Tony Wing-Lai Mak
Journal:  Clin Biochem Rev       Date:  2019-11

Review 3.  Superwarfarin poisoning: a significant public health problem.

Authors:  A E Rauch; R Weininger; D Pasquale; P T Burkart; H G Dunn; C Weissman; E Rydzak
Journal:  J Community Health       Date:  1994-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.